| 000 | 01658 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516104011.0 | ||
| 264 | 0 | _c20130306 | |
| 008 | 201303s 0 0 eng d | ||
| 022 | _a1468-2060 | ||
| 024 | 7 |
_a10.1136/annrheumdis-2012-202071 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPollard, Rodney P E | |
| 245 | 0 | 0 |
_aSerum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cJan 2013 |
||
| 300 |
_a146-8 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aB-Cell Activating Factor _xblood |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aSjogren's Syndrome _xblood |
| 650 | 0 | 4 |
_aTumor Necrosis Factor Ligand Superfamily Member 13 _xblood |
| 700 | 1 | _aAbdulahad, Wayel H | |
| 700 | 1 | _aVissink, Arjan | |
| 700 | 1 | _aHamza, Nishath | |
| 700 | 1 | _aBurgerhof, Johannes G M | |
| 700 | 1 | _aMeijer, Jiska M | |
| 700 | 1 | _aVisser, Annie | |
| 700 | 1 | _aHuitema, Minke G | |
| 700 | 1 | _aSpijkervet, Fred K L | |
| 700 | 1 | _aKallenberg, Cees G M | |
| 700 | 1 | _aBootsma, Hendrika | |
| 700 | 1 | _aKroese, Frans G M | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 72 _gno. 1 _gp. 146-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/annrheumdis-2012-202071 _zAvailable from publisher's website |
| 999 |
_c21990730 _d21990730 |
||